Citation Impact
Citing Papers
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
2016
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
2020
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
2020
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
2017
Nasopharyngeal carcinoma
2015 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
MiRNA-mediated EMT and CSCs in cancer chemoresistance
2021
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
2020
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
2019
Implications of the tumor immune microenvironment for staging and therapeutics
2017
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Hyperprogressive disease: recognizing a novel pattern to improve patient management
2018
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
2020
Emerging role of nanog in tumorigenesis and cancer stem cells
2013
Usage of social media during the pandemic: Seeking support and awareness about COVID-19 through social media platforms
2020 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Toward an understanding of regulatory T cells in COVID‐19: A systematic review
2021
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
2020
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Multigene pathway‐based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT‐CLPTM1L and DNA double‐strand breaks repair
2014
Works of Si-Pei Wu being referenced
MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells
2012
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics
2020
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
2016
Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma
2013
A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
2020
Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy
2017
Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer
2013